Luxembourg, 28 May 2020 – CordenPharma, a full-service Contract Development & Manufacturing Organization (CDMO) for the supply of APIs, Drug...
LATEST ICIG NEWS
CordenPharma & Moderna Extend Strategic Manufacturing Services Agreement for the Supply of Lipid Excipients to be used in Moderna’s Vaccine (mRNA-1273) Against the Novel Coronavirus SARS-CoV-2
ICIG announces the appointment of Dr. Michael Quirmbach as CEO & President of CordenPharma Group
CordenPharma Group, the global pharmaceutical service & manufacturing platform of International Chemical Investors Group (ICIG), is pleased to announce...
Thann production site joins Vynova Group, reinforcing Vynova’s leading position in potassium derivatives
On 1 July 2019, Potasse et Produits Chimiques SAS has joined Vynova Group. The company, based in Thann (France), has been renamed Vynova PPC SAS. The...
WeylChem Group acquires the homecare and process catalyst business of Catexel Group
Effective November 1, 2018, International Chemical Investors Group (ICIG) and WeylChem Group have acquired the Homecare, Cellulosics and Synthesis...